+91-22-48913909
Fincash » Mutual Funds » Best Performing Sector Funds for 2018
Table of Contents
- Top 10 Performing Sector Mutual Funds for 2024 Based on Performance
- Best Performing Sector Funds for 2024
Top 10 Equity - Sectoral Funds
Best 10 Performing Sector Funds for 2024
Sector Mutual Funds refer to the scheme that invest a predominant stake of their fund money in equity shares of companies belonging to a particular sector. These schemes are sought after by individuals who are looking for High Returns on their investment along with a High Risk appetite. Some of the sectors in which Mutual Funds generally offer their schemes include infrastructure, pharmaceutical, banking and financial services, and natural resources and new energy. The performance of sectoral funds for the year 2024 has been considerably good. With the developments in the Economy, many of the sectoral funds have generated positive returns on their investments. So, let us look at some of the top and best 10 performing sector Mutual Funds for the year 2024 on the Basis of their performance (returns).
Talk to our investment specialist
Top 10 Performing Sector Mutual Funds for 2024 Based on Performance
Fund NAV Net Assets (Cr) 2024 (%) 2023 (%) 2022 (%) 2021 (%) 2020 (%) LIC MF Infrastructure Fund Growth ₹47.6892
↑ 0.88 ₹874 47.8 44.4 7.9 46.6 -0.1 UTI Healthcare Fund Growth ₹272.199
↓ -0.51 ₹1,042 42.9 38.2 -12.3 19.1 67.4 SBI Healthcare Opportunities Fund Growth ₹418.188
↑ 2.40 ₹3,611 42.2 38.2 -6 20.1 65.8 TATA India Pharma & Healthcare Fund Growth ₹29.5738
↓ -0.03 ₹1,184 40.4 36.6 -8 19.1 64.4 IDFC Infrastructure Fund Growth ₹50.063
↑ 0.44 ₹1,563 39.3 50.3 1.7 64.8 6.3 Franklin India Opportunities Fund Growth ₹247.418
↑ 0.92 ₹6,047 37.3 53.6 -1.9 29.7 27.3 L&T Business Cycles Fund Growth ₹42.0307
↑ 0.38 ₹967 36.3 31.3 5.3 34.5 9.3 Canara Robeco Infrastructure Growth ₹155.92
↑ 1.35 ₹815 35.3 41.2 9 56.1 9 Nippon India Pharma Fund Growth ₹497.372
↑ 0.62 ₹8,081 34 39.2 -9.9 23.9 66.4 Invesco India Infrastructure Fund Growth ₹62.33
↑ 0.51 ₹1,410 33.2 51.1 2.3 55.4 16.2 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 16 May 25
Best Performing Sector Funds for 2024
The investment objective of the scheme is to provide long term growth from a portfolio of equity / equity related instruments of companies engaged either directly or indirectly in the infrastructure sector. LIC MF Infrastructure Fund is a Equity - Sectoral fund was launched on 29 Feb 08. It is a fund with High risk and has given a Below is the key information for LIC MF Infrastructure Fund Returns up to 1 year are on (Erstwhile UTI Pharma & Healthcare Fund) The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. UTI Healthcare Fund is a Equity - Sectoral fund was launched on 28 Jun 99. It is a fund with High risk and has given a Below is the key information for UTI Healthcare Fund Returns up to 1 year are on (Erstwhile SBI Pharma Fund) To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. SBI Healthcare Opportunities Fund is a Equity - Sectoral fund was launched on 31 Dec 04. It is a fund with High risk and has given a Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns. TATA India Pharma & Healthcare Fund is a Equity - Sectoral fund was launched on 28 Dec 15. It is a fund with High risk and has given a Below is the key information for TATA India Pharma & Healthcare Fund Returns up to 1 year are on The investment objective of the scheme is to seek to generate long-term capital growth through an active diversified portfolio of predominantly equity and equity related instruments of companies that are participating in and benefiting from growth in Indian infrastructure and infrastructural related activities. However, there can be no assurance that the investment objective of the scheme will be realized. IDFC Infrastructure Fund is a Equity - Sectoral fund was launched on 8 Mar 11. It is a fund with High risk and has given a Below is the key information for IDFC Infrastructure Fund Returns up to 1 year are on The investment objective of Franklin India Opportunities Fund (FIOF) is to generate capital appreciation by capitalizing on the long-term growth opportunities in the Indian economy. Franklin India Opportunities Fund is a Equity - Sectoral fund was launched on 21 Feb 00. It is a fund with Moderately High risk and has given a Below is the key information for Franklin India Opportunities Fund Returns up to 1 year are on To seek to generate long-term capital appreciation from a diversified portfolio of predominantly equity and equity related securities, including equity derivatives, in the Indian market with focus on riding business cycles through dynamic allocation between various sectors and stocks at different stages of business cycles in the economy L&T Business Cycles Fund is a Equity - Sectoral fund was launched on 20 Aug 14. It is a fund with Moderately High risk and has given a Below is the key information for L&T Business Cycles Fund Returns up to 1 year are on T o g e n e r a t e income/capital appreciation by investing in equities and equity related instruments of companies in the infrastructure sector. However, there can be no assurance that the investment objective of the scheme will be realized. Canara Robeco Infrastructure is a Equity - Sectoral fund was launched on 2 Dec 05. It is a fund with High risk and has given a Below is the key information for Canara Robeco Infrastructure Returns up to 1 year are on The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies. Nippon India Pharma Fund is a Equity - Sectoral fund was launched on 5 Jun 04. It is a fund with High risk and has given a Below is the key information for Nippon India Pharma Fund Returns up to 1 year are on The Scheme seeks to provide long term capital appreciation by investing in a portfolio that is predominantly constituted of equity and equity related instruments of infrastructure companies. However, there can be no assurance that the investment objective of the Scheme will be achieved. Invesco India Infrastructure Fund is a Equity - Sectoral fund was launched on 21 Nov 07. It is a fund with High risk and has given a Below is the key information for Invesco India Infrastructure Fund Returns up to 1 year are on 1. LIC MF Infrastructure Fund
CAGR/Annualized return of 9.4% since its launch. Return for 2024 was 47.8% , 2023 was 44.4% and 2022 was 7.9% . LIC MF Infrastructure Fund
Growth Launch Date 29 Feb 08 NAV (16 May 25) ₹47.6892 ↑ 0.88 (1.89 %) Net Assets (Cr) ₹874 on 31 Mar 25 Category Equity - Sectoral AMC LIC Mutual Fund Asset Mgmt Co Ltd Rating Risk High Expense Ratio 2.3 Sharpe Ratio 0.41 Information Ratio 0.35 Alpha Ratio 15.98 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Apr 20 ₹10,000 30 Apr 21 ₹14,908 30 Apr 22 ₹19,688 30 Apr 23 ₹21,272 30 Apr 24 ₹36,718 30 Apr 25 ₹38,183 Returns for LIC MF Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 16 May 25 Duration Returns 1 Month 8.8% 3 Month 14% 6 Month -3.2% 1 Year 9% 3 Year 31.4% 5 Year 34% 10 Year 15 Year Since launch 9.4% Historical performance (Yearly) on absolute basis
Year Returns 2024 47.8% 2023 44.4% 2022 7.9% 2021 46.6% 2020 -0.1% 2019 13.3% 2018 -14.6% 2017 42.2% 2016 -2.2% 2015 -6.2% Fund Manager information for LIC MF Infrastructure Fund
Name Since Tenure Yogesh Patil 18 Sep 20 4.62 Yr. Mahesh Bendre 1 Jul 24 0.83 Yr. Data below for LIC MF Infrastructure Fund as on 31 Mar 25
Equity Sector Allocation
Sector Value Industrials 57.02% Basic Materials 9.14% Consumer Cyclical 8.07% Utility 7.19% Financial Services 6.17% Real Estate 3.11% Technology 2.31% Communication Services 2.26% Health Care 0.51% Energy 0.44% Asset Allocation
Asset Class Value Cash 3.8% Equity 96.2% Top Securities Holdings / Portfolio
Name Holding Value Quantity Shakti Pumps (India) Ltd (Industrials)
Equity, Since 31 Mar 24 | SHAKTIPUMP4% ₹34 Cr 408,127 Garware Hi-Tech Films Ltd (Basic Materials)
Equity, Since 31 Aug 23 | 5006553% ₹30 Cr 94,287 Tata Power Co Ltd (Utilities)
Equity, Since 29 Feb 24 | 5004003% ₹28 Cr 724,927 Bharat Heavy Electricals Ltd (Industrials)
Equity, Since 31 May 24 | 5001033% ₹24 Cr 1,062,199
↑ 79,197 REC Ltd (Financial Services)
Equity, Since 31 Jul 23 | 5329553% ₹24 Cr 571,332 Hitachi Energy India Ltd Ordinary Shares (Industrials)
Equity, Since 31 Jul 22 | POWERINDIA3% ₹23 Cr 15,928
↑ 2,851 Afcons Infrastructure Ltd (Industrials)
Equity, Since 31 Oct 24 | AFCONS3% ₹22 Cr 537,216
↑ 46,853 Hindustan Aeronautics Ltd Ordinary Shares (Industrials)
Equity, Since 31 Oct 23 | HAL2% ₹22 Cr 49,106
↑ 3,972 TD Power Systems Ltd (Industrials)
Equity, Since 30 Apr 23 | TDPOWERSYS2% ₹21 Cr 476,469 GE Vernova T&D India Ltd (Industrials)
Equity, Since 31 Jan 24 | 5222752% ₹20 Cr 126,914 2. UTI Healthcare Fund
CAGR/Annualized return of 14.9% since its launch. Ranked 40 in Sectoral category. Return for 2024 was 42.9% , 2023 was 38.2% and 2022 was -12.3% . UTI Healthcare Fund
Growth Launch Date 28 Jun 99 NAV (16 May 25) ₹272.199 ↓ -0.51 (-0.19 %) Net Assets (Cr) ₹1,042 on 31 Mar 25 Category Equity - Sectoral AMC UTI Asset Management Company Ltd Rating ☆ Risk High Expense Ratio 2.38 Sharpe Ratio 0.66 Information Ratio -0.23 Alpha Ratio 1.04 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Apr 20 ₹10,000 30 Apr 21 ₹15,214 30 Apr 22 ₹15,571 30 Apr 23 ₹15,015 30 Apr 24 ₹22,423 30 Apr 25 ₹27,036 Returns for UTI Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 16 May 25 Duration Returns 1 Month 2.7% 3 Month 6.2% 6 Month -2.2% 1 Year 21.5% 3 Year 23.6% 5 Year 22.5% 10 Year 15 Year Since launch 14.9% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.9% 2023 38.2% 2022 -12.3% 2021 19.1% 2020 67.4% 2019 1.2% 2018 -7.5% 2017 6.2% 2016 -9.7% 2015 12.4% Fund Manager information for UTI Healthcare Fund
Name Since Tenure Kamal Gada 2 May 22 3 Yr. Data below for UTI Healthcare Fund as on 31 Mar 25
Equity Sector Allocation
Sector Value Health Care 97.95% Basic Materials 0.97% Asset Allocation
Asset Class Value Cash 1.08% Equity 98.92% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA12% ₹123 Cr 672,889
↓ -27,111 Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 5000876% ₹62 Cr 400,000
↓ -20,000 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDY5% ₹47 Cr 396,000 Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | 5323315% ₹47 Cr 172,829
↓ -2,056 Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Dec 20 | PGHL4% ₹41 Cr 79,763
↑ 5,763 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSP4% ₹39 Cr 56,271 Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | 5322964% ₹38 Cr 275,250 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB3% ₹34 Cr 56,000 Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 May 21 | ALKEM3% ₹33 Cr 63,840 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | 5328433% ₹32 Cr 465,000 3. SBI Healthcare Opportunities Fund
CAGR/Annualized return of 15.5% since its launch. Ranked 34 in Sectoral category. Return for 2024 was 42.2% , 2023 was 38.2% and 2022 was -6% . SBI Healthcare Opportunities Fund
Growth Launch Date 31 Dec 04 NAV (15 May 25) ₹418.188 ↑ 2.40 (0.58 %) Net Assets (Cr) ₹3,611 on 31 Mar 25 Category Equity - Sectoral AMC SBI Funds Management Private Limited Rating ☆☆ Risk High Expense Ratio 2.09 Sharpe Ratio 0.77 Information Ratio 0.67 Alpha Ratio 2.51 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Apr 20 ₹10,000 30 Apr 21 ₹15,282 30 Apr 22 ₹15,865 30 Apr 23 ₹16,168 30 Apr 24 ₹24,854 30 Apr 25 ₹30,132 Returns for SBI Healthcare Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 16 May 25 Duration Returns 1 Month 2.2% 3 Month 5.7% 6 Month 1.2% 1 Year 20.7% 3 Year 27.4% 5 Year 24.9% 10 Year 15 Year Since launch 15.5% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.2% 2023 38.2% 2022 -6% 2021 20.1% 2020 65.8% 2019 -0.5% 2018 -9.9% 2017 2.1% 2016 -14% 2015 27.1% Fund Manager information for SBI Healthcare Opportunities Fund
Name Since Tenure Tanmaya Desai 1 Jun 11 13.92 Yr. Data below for SBI Healthcare Opportunities Fund as on 31 Mar 25
Equity Sector Allocation
Sector Value Health Care 91.24% Basic Materials 6.15% Asset Allocation
Asset Class Value Cash 2.6% Equity 97.4% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA14% ₹513 Cr 2,800,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB7% ₹243 Cr 400,000
↑ 25,000 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 21 | MAXHEALTH6% ₹231 Cr 2,100,000
↓ -100,000 Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | 5000875% ₹186 Cr 1,200,000 Lonza Group Ltd ADR (Healthcare)
Equity, Since 31 Jan 24 | LO3A5% ₹182 Cr 300,000 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 23 | 5002575% ₹176 Cr 840,000 Poly Medicure Ltd (Healthcare)
Equity, Since 31 Aug 24 | POLYMED4% ₹139 Cr 540,000 Mankind Pharma Ltd (Healthcare)
Equity, Since 30 Apr 23 | MANKIND4% ₹138 Cr 560,000 Krishna Institute of Medical Sciences Ltd (Healthcare)
Equity, Since 30 Nov 22 | 5433084% ₹134 Cr 2,034,372
↓ -65,628 Jupiter Life Line Hospitals Ltd (Healthcare)
Equity, Since 31 Aug 23 | JLHL3% ₹117 Cr 800,000 4. TATA India Pharma & Healthcare Fund
CAGR/Annualized return of 12.3% since its launch. Return for 2024 was 40.4% , 2023 was 36.6% and 2022 was -8% . TATA India Pharma & Healthcare Fund
Growth Launch Date 28 Dec 15 NAV (16 May 25) ₹29.5738 ↓ -0.03 (-0.12 %) Net Assets (Cr) ₹1,184 on 31 Mar 25 Category Equity - Sectoral AMC Tata Asset Management Limited Rating Risk High Expense Ratio 0 Sharpe Ratio 0.42 Information Ratio 0.57 Alpha Ratio 2.09 Min Investment 5,000 Min SIP Investment 150 Exit Load 0-3 Months (0.25%),3 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Apr 20 ₹10,000 30 Apr 21 ₹14,766 30 Apr 22 ₹15,521 30 Apr 23 ₹15,212 30 Apr 24 ₹23,213 30 Apr 25 ₹27,062 Returns for TATA India Pharma & Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 16 May 25 Duration Returns 1 Month 3.3% 3 Month 6.2% 6 Month 0.6% 1 Year 17.4% 3 Year 23.7% 5 Year 22.5% 10 Year 15 Year Since launch 12.3% Historical performance (Yearly) on absolute basis
Year Returns 2024 40.4% 2023 36.6% 2022 -8% 2021 19.1% 2020 64.4% 2019 5.5% 2018 -2.6% 2017 4.7% 2016 -14.7% 2015 Fund Manager information for TATA India Pharma & Healthcare Fund
Name Since Tenure Meeta Shetty 9 Mar 21 4.15 Yr. Rajat Srivastava 16 Sep 24 0.62 Yr. Data below for TATA India Pharma & Healthcare Fund as on 31 Mar 25
Equity Sector Allocation
Sector Value Health Care 91.11% Basic Materials 2.29% Asset Allocation
Asset Class Value Cash 6.59% Equity 93.41% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMA13% ₹157 Cr 854,300
↑ 50,000 Cipla Ltd (Healthcare)
Equity, Since 30 Apr 20 | 5000876% ₹76 Cr 490,000 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 30 Apr 20 | AUROPHARMA6% ₹76 Cr 615,100
↓ -125,900 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Dec 16 | APOLLOHOSP6% ₹71 Cr 101,255 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB5% ₹64 Cr 104,965 Lupin Ltd (Healthcare)
Equity, Since 30 Nov 17 | 5002575% ₹64 Cr 303,240 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Oct 20 | 5328435% ₹59 Cr 855,100 Aster DM Healthcare Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Dec 22 | ASTERDM4% ₹48 Cr 956,991 Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 20 | ALKEM3% ₹38 Cr 75,249 HealthCare Global Enterprises Ltd (Healthcare)
Equity, Since 31 Dec 18 | HCG3% ₹37 Cr 666,121 5. IDFC Infrastructure Fund
CAGR/Annualized return of 12% since its launch. Ranked 1 in Sectoral category. Return for 2024 was 39.3% , 2023 was 50.3% and 2022 was 1.7% . IDFC Infrastructure Fund
Growth Launch Date 8 Mar 11 NAV (16 May 25) ₹50.063 ↑ 0.44 (0.88 %) Net Assets (Cr) ₹1,563 on 31 Mar 25 Category Equity - Sectoral AMC IDFC Asset Management Company Limited Rating ☆☆☆☆☆ Risk High Expense Ratio 2.33 Sharpe Ratio 0.11 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-365 Days (1%),365 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Apr 20 ₹10,000 30 Apr 21 ₹17,502 30 Apr 22 ₹22,498 30 Apr 23 ₹24,884 30 Apr 24 ₹44,570 30 Apr 25 ₹44,537 Returns for IDFC Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 16 May 25 Duration Returns 1 Month 7.2% 3 Month 15.6% 6 Month 0.1% 1 Year 3.9% 3 Year 32% 5 Year 37.5% 10 Year 15 Year Since launch 12% Historical performance (Yearly) on absolute basis
Year Returns 2024 39.3% 2023 50.3% 2022 1.7% 2021 64.8% 2020 6.3% 2019 -5.3% 2018 -25.9% 2017 58.7% 2016 10.7% 2015 -0.2% Fund Manager information for IDFC Infrastructure Fund
Name Since Tenure Vishal Biraia 24 Jan 24 1.27 Yr. Ritika Behera 7 Oct 23 1.57 Yr. Gaurav Satra 7 Jun 24 0.9 Yr. Data below for IDFC Infrastructure Fund as on 31 Mar 25
Equity Sector Allocation
Sector Value Industrials 56.16% Utility 13.16% Basic Materials 9.87% Communication Services 4.63% Energy 3.69% Financial Services 2.72% Consumer Cyclical 2.55% Technology 2.5% Health Care 1.93% Asset Allocation
Asset Class Value Cash 2.79% Equity 97.21% Top Securities Holdings / Portfolio
Name Holding Value Quantity Kirloskar Brothers Ltd (Industrials)
Equity, Since 31 Dec 17 | KIRLOSBROS5% ₹76 Cr 443,385 Larsen & Toubro Ltd (Industrials)
Equity, Since 29 Feb 12 | LT4% ₹64 Cr 183,173 UltraTech Cement Ltd (Basic Materials)
Equity, Since 31 Mar 14 | 5325384% ₹58 Cr 50,452 Reliance Industries Ltd (Energy)
Equity, Since 30 Jun 24 | RELIANCE4% ₹58 Cr 452,706 GPT Infraprojects Ltd (Industrials)
Equity, Since 30 Nov 17 | GPTINFRA4% ₹57 Cr 4,797,143 Bharti Airtel Ltd (Communication Services)
Equity, Since 30 Apr 19 | BHARTIARTL4% ₹57 Cr 330,018 Adani Ports & Special Economic Zone Ltd (Industrials)
Equity, Since 31 Dec 23 | ADANIPORTS3% ₹43 Cr 365,137 Bharat Electronics Ltd (Industrials)
Equity, Since 31 Oct 19 | BEL3% ₹43 Cr 1,431,700 KEC International Ltd (Industrials)
Equity, Since 30 Jun 24 | 5327143% ₹40 Cr 512,915 PTC India Financial Services Ltd (Financial Services)
Equity, Since 31 Dec 23 | PFS2% ₹39 Cr 12,400,122 6. Franklin India Opportunities Fund
CAGR/Annualized return of 13.5% since its launch. Ranked 47 in Sectoral category. Return for 2024 was 37.3% , 2023 was 53.6% and 2022 was -1.9% . Franklin India Opportunities Fund
Growth Launch Date 21 Feb 00 NAV (16 May 25) ₹247.418 ↑ 0.92 (0.37 %) Net Assets (Cr) ₹6,047 on 31 Mar 25 Category Equity - Sectoral AMC Franklin Templeton Asst Mgmt(IND)Pvt Ltd Rating ☆☆☆ Risk Moderately High Expense Ratio 2.12 Sharpe Ratio 0.46 Information Ratio 1.68 Alpha Ratio 8.45 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Apr 20 ₹10,000 30 Apr 21 ₹16,448 30 Apr 22 ₹17,903 30 Apr 23 ₹20,313 30 Apr 24 ₹35,875 30 Apr 25 ₹39,068 Returns for Franklin India Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 16 May 25 Duration Returns 1 Month 7.3% 3 Month 10.9% 6 Month 2.6% 1 Year 11.8% 3 Year 36.1% 5 Year 34.1% 10 Year 15 Year Since launch 13.5% Historical performance (Yearly) on absolute basis
Year Returns 2024 37.3% 2023 53.6% 2022 -1.9% 2021 29.7% 2020 27.3% 2019 5.4% 2018 -10.1% 2017 35.6% 2016 4.2% 2015 2.3% Fund Manager information for Franklin India Opportunities Fund
Name Since Tenure Kiran Sebastian 7 Feb 22 3.23 Yr. R. Janakiraman 1 Apr 13 12.09 Yr. Sandeep Manam 18 Oct 21 3.54 Yr. Data below for Franklin India Opportunities Fund as on 31 Mar 25
Equity Sector Allocation
Sector Value Consumer Cyclical 17.84% Financial Services 14.15% Health Care 11.48% Communication Services 8.89% Basic Materials 8.36% Technology 7.72% Industrials 6.32% Consumer Defensive 4.6% Energy 4.19% Real Estate 2.15% Utility 1.44% Asset Allocation
Asset Class Value Cash 10.49% Equity 89.51% Top Securities Holdings / Portfolio
Name Holding Value Quantity HDFC Bank Ltd (Financial Services)
Equity, Since 31 May 24 | HDFCBANK6% ₹374 Cr 2,043,971
↑ 308,675 Reliance Industries Ltd (Energy)
Equity, Since 30 Apr 22 | RELIANCE4% ₹253 Cr 1,987,098 Bharti Airtel Ltd (Communication Services)
Equity, Since 31 Jan 24 | BHARTIARTL4% ₹233 Cr 1,342,233 Hindustan Unilever Ltd (Consumer Defensive)
Equity, Since 30 Jun 24 | HINDUNILVR3% ₹182 Cr 803,952
↑ 242,198 Mphasis Ltd (Technology)
Equity, Since 30 Nov 24 | 5262993% ₹178 Cr 710,533 Mahindra & Mahindra Ltd (Consumer Cyclical)
Equity, Since 31 May 24 | M&M3% ₹170 Cr 637,966 Lemon Tree Hotels Ltd (Consumer Cyclical)
Equity, Since 31 Aug 24 | LEMONTREE3% ₹165 Cr 12,833,401 Info Edge (India) Ltd (Communication Services)
Equity, Since 31 Jul 24 | NAUKRI3% ₹155 Cr 216,138 ICICI Bank Ltd (Financial Services)
Equity, Since 31 Jan 10 | ICICIBANK3% ₹155 Cr 1,148,695 APL Apollo Tubes Ltd (Basic Materials)
Equity, Since 31 Oct 24 | APLAPOLLO3% ₹152 Cr 998,385 7. L&T Business Cycles Fund
CAGR/Annualized return of 14.2% since its launch. Ranked 19 in Sectoral category. Return for 2024 was 36.3% , 2023 was 31.3% and 2022 was 5.3% . L&T Business Cycles Fund
Growth Launch Date 20 Aug 14 NAV (16 May 25) ₹42.0307 ↑ 0.38 (0.92 %) Net Assets (Cr) ₹967 on 31 Mar 25 Category Equity - Sectoral AMC L&T Investment Management Ltd Rating ☆☆☆☆ Risk Moderately High Expense Ratio 2.43 Sharpe Ratio 0.36 Information Ratio 0.76 Alpha Ratio 7.61 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-18 Months (1%),18 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Apr 20 ₹10,000 30 Apr 21 ₹15,642 30 Apr 22 ₹18,589 30 Apr 23 ₹20,659 30 Apr 24 ₹30,830 30 Apr 25 ₹32,682 Returns for L&T Business Cycles Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 16 May 25 Duration Returns 1 Month 7.2% 3 Month 14.3% 6 Month 1% 1 Year 11.6% 3 Year 27.1% 5 Year 29.8% 10 Year 15 Year Since launch 14.2% Historical performance (Yearly) on absolute basis
Year Returns 2024 36.3% 2023 31.3% 2022 5.3% 2021 34.5% 2020 9.3% 2019 5.3% 2018 -17.5% 2017 45.6% 2016 3.2% 2015 3.5% Fund Manager information for L&T Business Cycles Fund
Name Since Tenure Venugopal Manghat 20 Aug 14 10.7 Yr. Gautam Bhupal 1 Jun 23 1.92 Yr. Sonal Gupta 1 Jun 23 1.92 Yr. Data below for L&T Business Cycles Fund as on 31 Mar 25
Equity Sector Allocation
Sector Value Financial Services 32.49% Industrials 28.36% Consumer Cyclical 15.18% Basic Materials 11.48% Energy 6.32% Technology 1.3% Real Estate 0.86% Asset Allocation
Asset Class Value Cash 2.75% Equity 97.25% Top Securities Holdings / Portfolio
Name Holding Value Quantity ICICI Bank Ltd (Financial Services)
Equity, Since 31 Aug 14 | ICICIBANK6% ₹57 Cr 425,000 Reliance Industries Ltd (Energy)
Equity, Since 31 Aug 18 | RELIANCE5% ₹51 Cr 401,700 Trent Ltd (Consumer Cyclical)
Equity, Since 31 Dec 16 | 5002515% ₹51 Cr 95,680 Multi Commodity Exchange of India Ltd (Financial Services)
Equity, Since 31 Dec 22 | MCX5% ₹50 Cr 94,300 HDFC Bank Ltd (Financial Services)
Equity, Since 31 Aug 14 | HDFCBANK5% ₹45 Cr 246,800 Bharat Electronics Ltd (Industrials)
Equity, Since 31 Dec 22 | BEL3% ₹30 Cr 1,000,000 Larsen & Toubro Ltd (Industrials)
Equity, Since 31 Aug 14 | LT3% ₹29 Cr 81,830 Blue Star Ltd (Industrials)
Equity, Since 31 Aug 14 | BLUESTARCO3% ₹26 Cr 119,800 Power Finance Corp Ltd (Financial Services)
Equity, Since 31 Jan 24 | 5328103% ₹25 Cr 603,200 Power Mech Projects Ltd (Industrials)
Equity, Since 31 Oct 22 | POWERMECH3% ₹25 Cr 90,800 8. Canara Robeco Infrastructure
CAGR/Annualized return of 15.1% since its launch. Return for 2024 was 35.3% , 2023 was 41.2% and 2022 was 9% . Canara Robeco Infrastructure
Growth Launch Date 2 Dec 05 NAV (16 May 25) ₹155.92 ↑ 1.35 (0.87 %) Net Assets (Cr) ₹815 on 31 Mar 25 Category Equity - Sectoral AMC Canara Robeco Asset Management Co. Ltd. Rating Risk High Expense Ratio 2.47 Sharpe Ratio 0.36 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Apr 20 ₹10,000 30 Apr 21 ₹15,419 30 Apr 22 ₹20,324 30 Apr 23 ₹23,066 30 Apr 24 ₹37,715 30 Apr 25 ₹40,093 Returns for Canara Robeco Infrastructure
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 16 May 25 Duration Returns 1 Month 7.7% 3 Month 16% 6 Month 1.3% 1 Year 7.9% 3 Year 31.1% 5 Year 34.4% 10 Year 15 Year Since launch 15.1% Historical performance (Yearly) on absolute basis
Year Returns 2024 35.3% 2023 41.2% 2022 9% 2021 56.1% 2020 9% 2019 2.3% 2018 -19.1% 2017 40.2% 2016 2.1% 2015 6.7% Fund Manager information for Canara Robeco Infrastructure
Name Since Tenure Vishal Mishra 26 Jun 21 3.85 Yr. Shridatta Bhandwaldar 29 Sep 18 6.59 Yr. Data below for Canara Robeco Infrastructure as on 31 Mar 25
Equity Sector Allocation
Sector Value Industrials 44.37% Utility 13.54% Basic Materials 10.26% Energy 8.83% Financial Services 6.7% Technology 4.4% Communication Services 3.04% Consumer Cyclical 2.7% Real Estate 1.54% Asset Allocation
Asset Class Value Cash 4.07% Equity 95.93% Top Securities Holdings / Portfolio
Name Holding Value Quantity Larsen & Toubro Ltd (Industrials)
Equity, Since 28 Feb 11 | LT6% ₹52 Cr 154,401
↑ 5,000 NTPC Ltd (Utilities)
Equity, Since 30 Nov 18 | 5325555% ₹38 Cr 1,066,480 Reliance Industries Ltd (Energy)
Equity, Since 30 Apr 22 | RELIANCE4% ₹37 Cr 264,250
↑ 10,000 InterGlobe Aviation Ltd (Industrials)
Equity, Since 31 Jan 23 | INDIGO4% ₹31 Cr 58,250 Tata Power Co Ltd (Utilities)
Equity, Since 30 Sep 24 | 5004004% ₹30 Cr 785,000 Power Grid Corp Of India Ltd (Utilities)
Equity, Since 31 Oct 09 | 5328984% ₹29 Cr 957,546 State Bank of India (Financial Services)
Equity, Since 31 Jul 24 | SBIN3% ₹29 Cr 370,000 Bharat Electronics Ltd (Industrials)
Equity, Since 31 Jul 19 | BEL3% ₹29 Cr 919,000 Dixon Technologies (India) Ltd (Technology)
Equity, Since 31 Oct 23 | DIXON3% ₹28 Cr 17,200
↑ 250 Power Finance Corp Ltd (Financial Services)
Equity, Since 30 Nov 23 | 5328103% ₹27 Cr 660,000 9. Nippon India Pharma Fund
CAGR/Annualized return of 20.5% since its launch. Ranked 35 in Sectoral category. Return for 2024 was 34% , 2023 was 39.2% and 2022 was -9.9% . Nippon India Pharma Fund
Growth Launch Date 5 Jun 04 NAV (16 May 25) ₹497.372 ↑ 0.62 (0.13 %) Net Assets (Cr) ₹8,081 on 31 Mar 25 Category Equity - Sectoral AMC Nippon Life Asset Management Ltd. Rating ☆☆ Risk High Expense Ratio 1.88 Sharpe Ratio 0.35 Information Ratio -0.49 Alpha Ratio -4.46 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Apr 20 ₹10,000 30 Apr 21 ₹15,389 30 Apr 22 ₹15,981 30 Apr 23 ₹15,783 30 Apr 24 ₹23,851 30 Apr 25 ₹27,660 Returns for Nippon India Pharma Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 16 May 25 Duration Returns 1 Month 2.9% 3 Month 6.9% 6 Month -0.2% 1 Year 15.4% 3 Year 22.9% 5 Year 22.8% 10 Year 15 Year Since launch 20.5% Historical performance (Yearly) on absolute basis
Year Returns 2024 34% 2023 39.2% 2022 -9.9% 2021 23.9% 2020 66.4% 2019 1.7% 2018 3.6% 2017 7.6% 2016 -10.6% 2015 19.4% Fund Manager information for Nippon India Pharma Fund
Name Since Tenure Sailesh Raj Bhan 1 Apr 05 20.09 Yr. Kinjal Desai 25 May 18 6.94 Yr. Data below for Nippon India Pharma Fund as on 31 Mar 25
Equity Sector Allocation
Sector Value Health Care 99.71% Asset Allocation
Asset Class Value Cash 0.29% Equity 99.71% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 09 | SUNPHARMA14% ₹1,146 Cr 6,256,349 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB10% ₹791 Cr 1,298,808 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 08 | 5002576% ₹521 Cr 2,483,991
↓ -414,135 Cipla Ltd (Healthcare)
Equity, Since 31 May 08 | 5000876% ₹496 Cr 3,200,000 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Sep 20 | APOLLOHOSP5% ₹453 Cr 648,795 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 30 Jun 11 | DRREDDY5% ₹434 Cr 3,662,170 GlaxoSmithKline Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Aug 22 | GLAXO4% ₹300 Cr 1,011,921 Medplus Health Services Ltd (Healthcare)
Equity, Since 30 Nov 22 | 5434274% ₹292 Cr 3,627,277 Vijaya Diagnostic Centre Ltd (Healthcare)
Equity, Since 30 Sep 21 | 5433503% ₹283 Cr 2,831,564 Abbott India Ltd (Healthcare)
Equity, Since 31 May 11 | ABBOTINDIA3% ₹267 Cr 88,883
↓ -2,050 10. Invesco India Infrastructure Fund
CAGR/Annualized return of 11% since its launch. Ranked 24 in Sectoral category. Return for 2024 was 33.2% , 2023 was 51.1% and 2022 was 2.3% . Invesco India Infrastructure Fund
Growth Launch Date 21 Nov 07 NAV (16 May 25) ₹62.33 ↑ 0.51 (0.82 %) Net Assets (Cr) ₹1,410 on 31 Mar 25 Category Equity - Sectoral AMC Invesco Asset Management (India) Private Ltd Rating ☆☆☆ Risk High Expense Ratio 2.34 Sharpe Ratio 0.05 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Apr 20 ₹10,000 30 Apr 21 ₹14,849 30 Apr 22 ₹19,717 30 Apr 23 ₹21,556 30 Apr 24 ₹37,479 30 Apr 25 ₹37,627 Returns for Invesco India Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 16 May 25 Duration Returns 1 Month 8.2% 3 Month 14.9% 6 Month -0.2% 1 Year 3.8% 3 Year 30.2% 5 Year 32.8% 10 Year 15 Year Since launch 11% Historical performance (Yearly) on absolute basis
Year Returns 2024 33.2% 2023 51.1% 2022 2.3% 2021 55.4% 2020 16.2% 2019 6.1% 2018 -15.8% 2017 48.1% 2016 0.8% 2015 -2.6% Fund Manager information for Invesco India Infrastructure Fund
Name Since Tenure Amit Nigam 3 Sep 20 4.66 Yr. Sagar Gandhi 1 Mar 25 0.17 Yr. Data below for Invesco India Infrastructure Fund as on 31 Mar 25
Equity Sector Allocation
Sector Value Industrials 54.81% Consumer Cyclical 8.5% Basic Materials 8.35% Utility 6.83% Communication Services 6.41% Health Care 4.5% Technology 2.94% Energy 2.55% Financial Services 2.01% Real Estate 1.45% Asset Allocation
Asset Class Value Cash 1.66% Equity 98.34% Top Securities Holdings / Portfolio
Name Holding Value Quantity Bharti Airtel Ltd (Communication Services)
Equity, Since 31 Aug 21 | BHARTIARTL6% ₹90 Cr 521,351 Power Grid Corp Of India Ltd (Utilities)
Equity, Since 30 Apr 22 | 5328984% ₹57 Cr 1,975,592
↓ -121,838 PTC Industries Ltd (Industrials)
Equity, Since 30 Sep 24 | 5390064% ₹57 Cr 37,885
↓ -755 ZF Commercial Vehicle Control Systems India Ltd (Consumer Cyclical)
Equity, Since 30 Jun 23 | ZFCVINDIA4% ₹52 Cr 40,213
↑ 3,977 Supreme Industries Ltd (Industrials)
Equity, Since 30 Apr 24 | 5099304% ₹49 Cr 144,264
↑ 24,429 Jyoti CNC Automation Ltd (Industrials)
Equity, Since 31 Jan 24 | JYOTICNC3% ₹48 Cr 452,265 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Jun 24 | APOLLOHOSP3% ₹47 Cr 71,172
↑ 18,503 KEC International Ltd (Industrials)
Equity, Since 31 Jan 25 | 5327143% ₹44 Cr 567,255
↑ 72,158 Larsen & Toubro Ltd (Industrials)
Equity, Since 29 Feb 12 | LT3% ₹43 Cr 123,555
↓ -25,817 Transformers & Rectifiers (India) Ltd (Industrials)
Equity, Since 30 Jun 24 | TARIL3% ₹43 Cr 795,318
↓ -105,820
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data. Please verify with scheme information document before making any investment.
You Might Also Like
AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153
Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.
©2025 Shepard Technologies Private Limited. All Rights Reserved